BiomX Inc. Files Form 8-K: Promissory Note Amendment, Share Issuance, and Related Party Transaction
Key Points from the SEC Filing
- Promissory Note Amendment: BiomX Inc. (NYSEAMER: PHGE) has executed an Amendment No. 1 and Waiver to an outstanding promissory note with Water IO Ltd., dated as of July 24, 2026.
- Repayment Terms Updated: The remaining principal of the note will be repaid in four equal monthly cash installments of \$250,000 each, due on August 1, September 1, October 1, and November 1, 2026.
- Share Issuance to Water IO: In full satisfaction of all accrued interest on the note, and as consideration for the delay in payment and the waivers provided, BiomX will issue 800,000 shares of its common stock (par value \$0.0001 per share) to Water IO, subject to NYSE American clearance and required corporate approvals.
- Restricted Securities: The shares will be issued without registration under the Securities Act of 1933, relying on exemptions (Section 4(a)(2) and/or Regulation S). These shares will be deemed “restricted securities” and bear customary restrictive legends.
- Related Party Transaction: A member of BiomX’s Board of Directors also serves as an independent director at Water IO. The amendment was approved by the Board and Audit Committee, with the interested director abstaining.
- Contingent Provisions: If required approvals are not confirmed by August 31, 2026, the accrued interest will be paid in cash instead, and the share issuance will not occur. The principal balance will continue to accrue interest at the short-term Applicable Federal Rate until fully paid.
- Regulatory Compliance: The transaction was reviewed and approved in accordance with BiomX’s related person transaction policy and relevant corporate governance procedures.
Potentially Price-Sensitive Information for Shareholders
- Dilution Impact: The issuance of 800,000 new shares represents a material increase in BiomX’s outstanding common stock, potentially diluting existing shareholders’ stakes.
- Cash Flow and Liquidity: The restructuring of the note to allow for phased repayment may have positive implications for BiomX’s short-term cash flow management.
- Related Party Considerations: The involvement of a Board member in both companies is a noteworthy governance matter, but the proper abstention and committee approval may mitigate conflict of interest concerns.
- Non-Registration of Shares: The restricted nature of the shares may limit immediate resale, but once eligible, could create additional selling pressure in the market.
- Conditionality of Share Issuance: The share issuance remains subject to exchange and corporate approvals, introducing uncertainty as to whether dilution will occur.
Other Important Details
- Trading Symbol: PHGE
- Exchange: NYSE American
- Form Type: 8-K (Current Report)
- Date of Report: July 27, 2026
- Signatory: Michael Oster, Chief Executive Officer
Conclusion
The amendment to the Water IO loan agreement and the related unregistered share issuance is a significant development for BiomX Inc. investors. The transaction affects both the company’s near-term financial flexibility and its capital structure. The share issuance, if completed, will increase total shares outstanding and could be dilutive. Shareholders should monitor subsequent disclosures for confirmation of approval and completion of the share issuance, as well as any market reaction to the news.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all official filings and consult their financial advisors before making investment decisions. The information herein is based on SEC filings as of July 27, 2026, and may be subject to change or further updates.
